Search Results 781-790 of 7361 for 不留痕搜索咨询邮箱:lgooxc@hotmail.com
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Anticipated time on study treatment is 1 year or until disease progression or unacceptable toxicity occurs. Participation eligibility. Participant eligibility ...
About this study. The purpose of this study is to compare cardiopulmonary exercise testing with no filter to pre- and post-flow sensor placement.
Faculty including scientists, engineers and physicians work together in the Department of Physiology and Biomedical Engineering at Mayo Clinic.
About this study. To evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific ...
Expert faculty members guide research and education in Mayo Clinic's Department of Quantitative Health Sciences.
Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed ...
A Phase 3 Study to Examine the Effectiveness, Safety and Tolerability of APL-130277 for the Acute Treatment of Motor Fluctuation Episodes in Patients with ...
The purpose of this study is to explore the experiences of patients and their family caregivers who use tube feeding in the home setting as part of Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.